| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $34.3M | — | -44.6% |
| R&D Expense | $6.4M | — | -45.1% |
| SG&A Expense | $8.3M | — | -39.9% |
| Operating Income | -$8.3M | — | +41.2% |
| Pre-tax Income | -$13.8M | — | -3.9% |
| Income Tax | $0 | — | — |
| Net Income | -$4.5M | — | +66.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.7M | -26.8% | -31.5% |
| Short-term Investments | $24.1M | — | — |
| Accounts Receivable | $63.1M | -23.7% | -34.4% |
| Current Assets | $128.5M | -6.4% | -18.1% |
| Total Assets | $263.9M | -7.6% | -28.5% |
| Current Liabilities | $59.4M | -24.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.6M | — | +15.9% |
| Capital Expenditures | $28K | — | -76.5% |
| Investing Cash Flow | -$2.3M | — | +41.0% |
| Financing Cash Flow | -$5.0M | — | -65.5% |
| Free Cash Flow | -$5.7M | — | +16.9% |
| -55.0% |
| Long-term Debt | $204.2M | -3.9% | -4.6% |
| Total Liabilities | $267.9M | -8.3% | -12.2% |
| Stockholders' Equity | -$4.0M | +38.5% | -106.2% |